Wanglong Deng
Research Subjects
Wanglong Deng has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Cong Pian
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, Jiangsu, China
14 shared publications - Jie Zhao
National Engineering Laboratory for Internet Medical Systems and Applications The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China
14 shared publications - Jinwen Ji
The State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China
14 shared publications - Lifeng Li
National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China
14 shared publications - Meijia Yang
National Engineering Laboratory for Internet Medical Systems and Applications The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China
14 shared publications - Rui Yan
Institute of Clinical Epidemiology, Key Laboratory of Public Health Safety, Ministry of Education, Key Lab of Health Technology Assessment of Ministry of Health, School of Public Health, Fudan University, Shanghai, China
14 shared publications
Latest Publications
- Open Access
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Background:Lung cancer is the most lethal malignancy worldwide and urgently requires effective early detection strategies. Current noninvasive approaches based on plasma cell-free DNA (cfDNA) fragmentomics often suffer from limited sensitivity in early-stage patients because of low tumor DNA fractions.Methods:We developed a novel computational feature, first-order transition probability (FOTP), to capture nucleotide sequential dependencies within cfDNA fragments. Using low-pass whole-genome sequencing data from 1,036 participants, we systematically analyzed cfDNA fragment ends to identify discriminative regions for cancer detection and trained a support vector machine (SVM) model leveraging the FOTP features.Results:Analysis revealed that the first 10 base pairs (bp) at the 5′-end of cfDNA fragments contained the most discriminative information. The SVM model achieved an area under the ROC curve of 0.942, with 73.9% sensitivity for stage I and 81.8% for stage II lung cancer at 95% specificity, significantly outperforming existing fragmentomic features. Nucleotide frequency stability and entropy patterns beyond the initial 10 bp supported the biological basis of the approach, reflecting nuclease cleavage biases and chromatin features. The method generalized robustly across independent cohorts and multicancer validation sets, showing potential for tissue-of-origin prediction.Conclusions:FOTP is a biologically interpretable and highly efficient feature for early cancer detection. It captures key nucleotide dependencies at cfDNA fragment ends, enhancing sensitivity for early-stage lung cancer and other cancers.Impact:This approach offers a scalable and generalizable strategy for early cancer screening.
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Background:Lung cancer is the most lethal malignancy worldwide and urgently requires effective early detection strategies. Current noninvasive approaches based on plasma cell-free DNA (cfDNA) fragmentomics often suffer from limited sensitivity in early-stage patients because of low tumor DNA fractions.Methods:We developed a novel computational feature, first-order transition probability (FOTP), to capture nucleotide sequential dependencies within cfDNA fragments. Using low-pass whole-genome sequencing data from 1,036 participants, we systematically analyzed cfDNA fragment ends to identify discriminative regions for cancer detection and trained a support vector machine (SVM) model leveraging the FOTP features.Results:Analysis revealed that the first 10 base pairs (bp) at the 5′-end of cfDNA fragments contained the most discriminative information. The SVM model achieved an area under the ROC curve of 0.942, with 73.9% sensitivity for stage I and 81.8% for stage II lung cancer at 95% specificity, significantly outperforming existing fragmentomic features. Nucleotide frequency stability and entropy patterns beyond the initial 10 bp supported the biological basis of the approach, reflecting nuclease cleavage biases and chromatin features. The method generalized robustly across independent cohorts and multicancer validation sets, showing potential for tissue-of-origin prediction.Conclusions:FOTP is a biologically interpretable and highly efficient feature for early cancer detection. It captures key nucleotide dependencies at cfDNA fragment ends, enhancing sensitivity for early-stage lung cancer and other cancers.Impact:This approach offers a scalable and generalizable strategy for early cancer screening.
- Open Access
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Sensitivity of FOTP-based model across different clinical subgroups in the independent cohort at 95% specificity
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Sensitivity of FOTP-based model across different clinical subgroups in the independent cohort at 95% specificity
- Open Access
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Number of Principal components explaining 99% of total variance
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Number of Principal components explaining 99% of total variance
- Open Access
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Model sensitivity based on FOTP features derived from sequences of varying lengths at 95% specificity
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Model sensitivity based on FOTP features derived from sequences of varying lengths at 95% specificity
- Open Access
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Tissue-of-origin results from the external multi-cancer dataset
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Tissue-of-origin results from the external multi-cancer dataset
- Open Access
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Classification score distributions across non-cancer individuals and cancer patients in the independent external test cohort
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Classification score distributions across non-cancer individuals and cancer patients in the independent external test cohort
- Open Access
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Nucleotide frequencies within the first 20 bp from fragment ends for healthy individuals and HCC patients
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Nucleotide frequencies within the first 20 bp from fragment ends for healthy individuals and HCC patients
- Open Access
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Nucleotide frequencies within the first 20 bp from fragment ends for a healthy individual and an LC patient
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Nucleotide frequencies within the first 20 bp from fragment ends for a healthy individual and an LC patient
- Open Access
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Sensitivity of FOTP-based models in consecutive 10-bp windows at 95% specificity
- 2 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA
Sensitivity of FOTP-based models in consecutive 10-bp windows at 95% specificity